WebJordan’s strengthened IP system has helped put the Jordanian pharmaceutical industry on the path of innovation. While many Jordanian companies were previously focusing on manufacturing generic drugs, Hikma is an example of a company that is now creating its own patentable drugs and innovations. Inspired by Hikma’s success, Jordanian ... WebApr 14, 2024 · Hikma Pharmaceuticals' mailing address is 1 New Burlington Place, LONDON, W1S 2HR, United Kingdom. The official website for the company is www.hikma.com. The company can be reached via phone at +44-20-73992760. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks.
Hikma Pharmaceuticals : Q3-Dynamik ähnlich wie in den …
WebStock analysis for Hikma Pharmaceuticals PLC (HIK:London) including stock price, stock chart, company news, key statistics, fundamentals and company profile. WebApr 12, 2024 · Hikma Pharmaceuticals PLC gibt bekannt, dass Riad Mishlawi, Präsident des Geschäftsbereichs Injectables der Gruppe, mit Wirkung vom 1. September 2024 zum Chief Executive Officer (CEO) ernannt wurde. Danach wird Said Darwazah als amtierender CEO zurücktreten und in seine Rolle als Executive Chairman zurückkehren. dallas bishop lynch athletics
Hikma Pharmaceuticals NEWS Nachrichten hier lesen! - ARIVA.DE
WebApr 12, 2024 · LONDON (dpa-AFX) - Hikma Pharmaceuticals PLC (HIK, HIK. L) gab am Mittwoch bekannt, dass es Riad Mishlawi, President des Geschäftsbereichs Injectables der Gruppe, mit Wirkung zum 1. September zum ... WebWebsite. www .hikma .com. Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of … WebNov 4, 2024 · Aktien. Vereinigtes Königreich. London Stock Exchange; Hikma Pharmaceuticals PLC. News. Übersicht HIK GB00B0LCW083. HIKMA PHARMACEUTICALS PLC ... Analystenempfehlungen zu HIKMA PHARMACEUTICALS PLC: 06.04. Goldman stuft Spirent von 'verkaufen' auf 'neutral' hoch: AN. 13.03. JPMorgan senkt BAT; erhöht Bunzl: AN. bipolartransistor wiki